Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Tiens Biotech Group (USA) Reports First Quarter Results


      News provided by

      Tiens Biotech Group (USA), Inc.

      May 16, 2011, 05:15 ET

      Share this article

      Share this article


      TIANJIN, China, May 16, 2011 /PRNewswire-Asia/ -- Tiens Biotech Group (USA), Inc. (the "Company" or "Tiens", NYSEAMEX: TBV), www.tiens-bio.com, a company dedicated to the research, development, manufacturing, and marketing of nutrition supplement products, including wellness products and dietary supplements, today announced financial results for the quarter ended March 31, 2011.

      Revenue for the first quarter of 2011 was $13.1 million, compared to $11.4 million for 2010.  

      Net income for first quarter of 2011 was $2.9 million, or $0.04 per share, compared to $3.6 million, or $0.05 per share for 2010.

      The 14.4% increase in revenue for the first quarter of 2011 mainly resulted from a 21.2% increase in domestic sales as compared to the year-ago period. There were two primary reasons for the robustness of the domestic market. First, distributors rushed to increase inventory in advance of the planned price increases for some products that were scheduled for March 2011. Additionally, Tiens began to see the effects of the long-awaited direct selling license that was awarded by the Ministry of Commerce of the People's Republic of China on March 11, 2011.  On the international front, Tiens experienced a modest 4.6% increase as a result of increased sales to South Africa.

      Net income, however, was negatively impacted by an increase of $1.4 million in selling, general and administrative expenses. This increase was primarily responsible for the 18.3% decrease in net income for the quarter and was mainly due to increases in depreciation related to the transfer of construction in progress to fixed assets.

      Other Highlights

      Cost of sales were $4.1 million in 2011 compared to $3.4 million in 2010, an increase of 20.2%. This increase was primarily due to the corresponding increase in sales. However, cost of sales rose at a higher rate than sales overall, as a result of a reduction in sales of the Company's higher margin products.  

      Gross profit increased by 11.9% to $8.9 million in 2011, compared to $8.0 million in 2010. The gross profit margin for 2011 was 68.3% compared to 69.8% for the same period in 2010.

      Selling, general and administrative expenses increased by 39.3% to $4.9 million in 2011, compared to $3.5 million in 2010. The increase was primarily due to the aforementioned increases in depreciation.

      As of March 31, 2011, Tiens had $130.7 million of retained earnings and total shareholders' equity of $190.1 million.

      Jinyuan Li, Chairman, President and CEO of Tiens, said, "We are pleased by the increase in sales this quarter and expect our new domestic selling license to be a growing contributor to revenue in the months and years ahead. In the international arena, we are confident that our operations will gradually improve as worldwide economic conditions continue to recover. Likewise, operational improvements made at the distributor level should also boost results over time.  Our commitment to both domestic and international growth remains steadfast as we continue to manage our business through the economic recovery and look ahead toward further execution of our strategic growth plans in both China and abroad."

      About Tiens Biotech Group (USA), Inc. www.tiens-bio.com

      Tiens Biotech Group (USA), Inc. (NYSEAMEX: TBV) conducts its business operations from Tianjin, People's Republic of China. Tiens primarily engages in the research, development, manufacturing, and marketing of nutrition supplement products, including wellness products and dietary supplements.

      Tiens derives its revenues principally from product sales to affiliated companies in China and internationally in 45 countries. Since its establishment, Tiens has developed and produced 37 nutrition supplements, which include wellness products and dietary supplements. Tiens develops its products at its own product research and development center, which employs highly qualified professionals in the fields of pharmacology, biology, chemistry and fine chemistry. Tiens has obtained all required certificates and approvals from government regulatory agencies to manufacture and sell its products in China.

      In China, Tiens conducts the marketing and sales of its products through its affiliated company, Tianshi Engineering. Tianshi Engineering markets and sells Tiens' products in China through chain stores, domestic affiliated companies, and its 87 branches.  Outside of China, Tiens sells its products to affiliated companies in 45 countries who in turn sell through an extensive direct sales force, or multi-level marketing sales force. The Company's direct sales marketing program is subject to governmental regulation in each of these countries.  

      Certain statements in this press release constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Such forward-looking statements are not necessarily indicative of future financial results, and may involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to: (i) the Company's ability to obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) the Company's ability to build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; (iv) whether the Company continues to experience delays in the export clearance of its products; and (v) other risk factors discussed in the Company's periodic filings with the Securities and Exchange Commission which are available for review at http://www.sec.gov.

      CONTACT:




      Investor Relations

      Debra Berliner

      Tiens Biotech Group (USA), Inc.

      G. S. Schwartz & Co.

      Tel:   +86-22-8213-3118

      Tel: 212-725-4500

      Fax:  +86-22-8213-7914

      Fax: 212-725-9188

      Email: [email protected]

      Email: [email protected]

      http://www.tiens-bio.com




      -Tables Follow-

      TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES


      CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME

      FOR THE THREE MONTHS ENDED MARCH 31, 2011 AND 2010 (UNAUDITED)






      Three months ended March 31,


      2011


      2010





      REVENUE-RELATED PARTIES

      $        13,050,225


      $        11,403,363





      COST OF SALES-RELATED PARTIES

      4,136,399


      3,440,881





      GROSS PROFIT

      8,913,826


      7,962,482





      SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

      4,870,886


      3,497,547





      INCOME FROM OPERATIONS

      4,042,940


      4,464,935





          Interest expense

      (131,636)


      -

          Interest income

      7,992


      1,872

          Other expense

      (529,185)


      (253,710)

      OTHER EXPENSE, NET

      (652,829)


      (251,838)





      INCOME BEFORE PROVISION FOR INCOME TAXES

      3,390,111


      4,213,097





      PROVISION FOR INCOME TAXES

      446,299


      609,502





      NET INCOME

      2,943,812


      3,603,595





             LESS: Net income attributable to the noncontrolling interest

      (190,204)


      (342,057)





      NET INCOME ATTRIBUTABLE TO THE COMPANY

      2,753,608


      3,261,538





      OTHER COMPREHENSIVE INCOME:




          Foreign currency translation adjustment

      1,012,022


      14,970





      COMPREHENSIVE INCOME ATTRIBUTABLE




      TO THE COMPANY

      3,765,630


      3,276,508





      COMPREHENSIVE INCOME ATTRIBUTABLE




      TO THE NONCONTROLLING INTEREST

      257,361


      343,398





      COMPREHENSIVE INCOME

      $         4,022,991


      $         3,619,906





      EARNINGS PER SHARE,




      BASIC AND DILUTED

      $ 0.04


      $ 0.05





      WEIGHTED AVERAGE NUMBER OF SHARES,




      BASIC AND DILUTED

      71,333,586


      71,333,586





      The accompanying notes are an integral part of this statement.



      TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES


      CONSOLIDATED BALANCE SHEETS

      AS OF MARCH 31, 2011 (UNAUDITED) AND DECEMBER 31, 2010 (AUDITED)










      March 31,


      December 31,


      2011


      2010


      (Unaudited)


      (Audited)

      ASSETS




      CURRENT ASSETS:




        Cash

      $        9,691,411


      $     10,155,522

        Accounts receivable, trade-related parties, net of




           allowance for doubtful accounts of $4,152,284 and $3,869,617




           as of March 31, 2011 and December 31, 2010, respectively

      11,279,779


      10,012,861

        Inventories

      6,801,856


      5,703,349

        Other receivables

      942,959


      1,045,952

        Other receivables-related parties

      17,327,387


      17,376,522

        Employee advances

      127,314


      170,842

        Prepaid expenses, net

      356,817


      415,208

        Prepaid taxes

      3,689,268


      3,646,140

           Total current assets

      50,216,791


      48,526,396





      PROPERTY, PLANT AND EQUIPMENT, net

      72,098,917


      72,037,542





      OTHER ASSETS:




        Construction in progress

      130,736,007


      128,715,283

        Construction deposits

      20,177,749


      12,490,855

        Intangible assets, net

      12,991,801


      12,987,000

        Other assets

      10,302,761


      10,721,040

           Total other assets

      174,208,318


      164,914,178





              Total assets

      $    296,524,026


      $    285,478,116





      LIABILITIES AND SHAREHOLDERS' EQUITY








      CURRENT LIABILITIES:




        Accounts payable

      $      14,719,467


      $      14,120,791

        Advances from customers-related parties

      7,546,016


      8,688,877

        Wages and benefits payable

      1,584,986


      1,613,782

        Short-term debt

      7,610,000


      3,024,800

        Income taxes payable

      717,129


      490,782

        Contractor deposits

      195,485


      209,376

        Contractor payables

      26,888,982


      28,134,711

        Other payables

      1,109,025


      1,113,416

        Other payables-related parties

      5,337,033


      1,417,516

           Total current liabilities

      65,708,123


      58,814,051





      NON-CURRENT LIABILITIES




        Long term debt

      18,568,400


      18,451,280

        Deferred income

      11,400,523


      11,473,853

           Total non current liabilities

      29,968,923


      29,925,133





           Total liabilities

      95,677,046


      88,739,184





      EQUITY:




        Shareholders' equity of the Company:




           Common stock, $0.001 par value, 250,000,000 shares authorized,




              71,333,586 issued and outstanding, respectively

      71,334


      71,334

           Paid-in-capital

      18,428,796


      18,349,908

           Statutory reserves

      16,465,144


      16,465,144

           Retained earnings

      130,711,559


      127,957,951

           Accumulated other comprehensive income

      24,405,648


      23,393,626

              Total shareholders' equity of the Company

      190,082,481


      186,237,963

           Noncontrolling interest

      10,764,499


      10,500,969

           Total equity

      200,846,980


      196,738,932

              Total liabilities and equity

      $     296,524,026


      $     285,478,116





      The accompanying notes are an integral part of this statement.



      TIENS BIOTECH GROUP (USA), INC. AND SUBSIDIARIES


      CONSOLIDATED STATEMENTS OF CASH FLOWS

      FOR THE THREE MONTHS ENDED MARCH 31, 2011 AND 2010 (UNAUDITED)






      Three months ended March 31,


      2011


      2010

      CASH FLOWS FROM OPERATING ACTIVITIES:




        Net income  

      $       2,943,812


      $      3,603,595

        Adjustments to reconcile net income to cash




           provided by (used in) operating activities:




              Deferred income

      (145,776)


      -

              Provision for doubtful accounts

      257,427


      202,247

              Depreciation

      1,117,611


      417,469

              Amortization

      85,020


      83,557

              loss on assets written off

      655,611


      -

              Gain on sale of assets

      -


      (15,082)

              Rental expense borne by a related party

      84,834


      81,749

            (Increase) decrease in assets:




              Accounts receivable, trade-related parties

      (1,457,625)


      4,933,543

              Other receivables

      109,344


      93,577

              Other receivables-related parties

      141,586


      (1,200,159)

              Inventories

      (1,050,293)


      304,560

              Employee advances

      44,495


      13,935

              Prepaid expense

      60,774


      64,017

           Increase (decrease) in liabilities:




              Accounts payable

      500,706


      (819,926)

              Advances from customers-related parties

      (1,194,866)


      4,034,448

              Wages and benefits payable

      (38,897)


      (416,798)

              Other taxes payable

      202,713


      550,140

              Other payables

      (11,159)


      19,487

              Other payables-related parties

      3,900,777


      1,079,414

                 Net cash provided by operating activities

      6,206,094


      13,029,773





      CASH FLOWS FROM INVESTING ACTIVITIES:




        Investment in Life Resources

      -


      3,000,000

        Proceeds from disposal of a subsidiary

      -


      700,000

        Construction deposits

      (7,783,013)


      (562,642)

        Contractor deposits

      (15,180)


      -

        Addition to construction in progress

      (2,729,380)


      (9,112,590)

        Equipment deposits

      (427,179)


      (1,558,192)

        Proceeds from sales of properties

      -


      2,621,021

        Purchase of equipment and automobiles

      (163,060)


      (88,505)

                 Net cash used in investing activities

      (11,117,812)


      (5,000,908)





      CASH FLOWS FROM FINANCING ACTIVITIES:




        Proceed from short term debt

      4,554,000


      -

                 Net cash provided by financing activities

      4,554,000


      -





      EFFECT OF EXCHANGE RATE CHANGES ON CASH

      (106,393)


      (3,895)





      NET INCREASE (DECREASE) IN CASH

      (464,111)


      8,024,970





      CASH, beginning of period

      10,155,522


      1,848,328









      CASH, end of period

      $      9 ,691,411


      $      9,873,298





      Supplemental disclosures of cash flow information




        Cash paid during the period for:




           Interest

      $          342,018


      $                     -

           Income taxes

      $          223,653


      $         213,625





      The accompanying notes are an integral part of this statement.



      REVENUE BY REGION






      Three months ended March 31,


      2011


      2010





      China

      $         8,218,691


      $        6,783,273

      International

      4,831,534


      4,620,090

      Total

      $       13,050,225


      $      11,403,363



      SOURCE Tiens Biotech Group (USA), Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.